JEFFERY SCHWAB: Open Payments
NPI 1679714299 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 16 payments from 7 companies in 2025. Trend: 2023 $358 · 2024 $523 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $149 |
| GlaxoSmithKline, LLC. | 3 | $83 |
| PFIZER INC. | 3 | $73 |
| Syndax Pharmaceuticals, Inc. | 1 | $25 |
| Novocure Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Stemline Therapeutics Inc. | 1 | $15 |
Products named: OJJAARA, SCEMBLIX, ELREXFIO, KISQALI, Fabhalta, Optune Lua (NovoTTF-200T), LUTATHERA, XTANDI.
Industry payments across OR — which companies pay providers there.
